Alpha-herpesvirus insensitive monoclonal cell strain, and preparation method therefor and use thereof
AssigneeHarbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences (China Animal Health and Epidemiology Center Harbin Branch Center)
InventorsXin Yin, Menghang Wang, Xing Liu
Life of this patent
Estimating the term…
Abstract
The present disclosure discloses an α-herpesvirus insensitive monoclonal cell strain, and a preparation method therefor and use thereof, belonging to the technical field of biomedicine. In order to perform targeted research of intercellular transmission of an α-herpesvirus and an action mechanism thereof, the present disclosure discloses the α-herpesvirus insensitive monoclonal cell strain. The cell strain is named as a human liver cancer continuous cell line Huh7-C10 and has a potential of being applied to developing a new generation of enhanced oncolytic herpesvirus and single-round infection attenuated live vaccine.
Claims4
An α-herpesvirus insensitive monoclonal cell strain, wherein the cell strain is a human liver cancer continuous cell line Huh7-C10 and deposited in the China General Microbiological Culture Collection Center with a deposit number of CGMCC NO. 45727 on Oct. 7, 2023.
Dependencies are inferred from the claim text.